Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: A CATIE study

American Journal of Psychiatry

Volumn 164, Issue 3, 2007, Pages 415-427

  Stroup, T Scott ^a   Lieberman, Jeffrey A ^b   McEvoy, Joseph P ^b   Swartz, Marvin S ^b   Davis, Sonia M ^b   Capuano, George A ^b   Rosenheck, Robert A ^b   Keefe, Richard S E ^b   Miller, Alexander L ^b   Belz, Irving ^b   Hsiao, John K ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYNDROME; FAINTNESS; FEMALE; GALACTORRHEA; GYNECOMASTIA; HUMAN; HYPERSALIVATION; INCONTINENCE; INSOMNIA; LIBIDO; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; NEUROLOGIC DISEASE; NOCTURIA; ORGASM DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHIZOPHRENIA; SEXUAL AROUSAL DISORDER; SIDE EFFECT; SOMNOLENCE; URINARY DYSFUNCTION; XEROSTOMIA;

EID: 34047139907     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.3.415     Document Type: Article

References (13)

1. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223
2. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RSE, Davis CE, Severe J, Hsiao JK, for CATIE Investigators: Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 2006; 163:600-610
3. Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RSE, Davis CE, Severe J, Hsiao JK, for the CATIE Investigators: Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry 2006; 163:611-622
4. Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M: Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. Schizophr Bull 2003; 29:45-55
5. Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA: The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003; 29:15-31
6. Swartz MS, Perkins DO, Stroup TS, McEvoy JP, Nieri JM, Haak DC: Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull 2003; 29:33-43
7. Davis SM, Koch GG, Davis CE, LaVange LM: Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the clinical antipsychotic trials of intervention effectiveness (CATIE) studies. Schizophr Bull 2003; 29:73-80
8. Cox D: Regression models and life tables. J R Statist Soc B 1972; 34:187-220
9. Kinon BJ, Lieberman JA: Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl) 1996; 124(1-2):2-34
10. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Schizophrenia, 2nd ed. Am J Psychiatry 2004; 161(Feb suppl):1-56
11. Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B: The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry 2004; 65:500-508
12. Treatment of Schizophrenia 1999: The Expert Consensus Guideline Series. J Clin Psychiatry 1999; 60(suppl 11):3-80
13. Pandiani JA, Banks SM: Interpreting the results of the CATIE study. Psychiatr Serv 2006; 57:140-141